[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370231-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370231-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeted-intervention-of-tumor-microenvironment-with-hdac-inhibitors-and-their-combination-therapy-strategies","Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies","","Histone deacetylation is a key epigenetic mechanism involving the removal of acetyl groups from histones, thereby regulating gene transcription. Overexpression of histone deacetylases (HDACs) is common across many cancer types, supporting HDAC inhibitors as broadly applicable therapeutic agents. These inhibitors can increase tumor immune antigenicity and may slow tumor progression. The tumor microenvironment links to cancer development and provides an actionable target. The paper examines how HDAC inhibitors modulate cancer progression through multiple tumor microenvironment pathways and evaluates synergistic effects from combination drug strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeted-intervention-of-tumor-microenvironment-with-hdac-inhibitors-and-their-combination-therapy-strategies/370231/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeted-intervention-of-tumor-microenvironment-with-hdac-inhibitors-and-their-combination-therapy-strategies/370231.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do HDACs influence gene transcription in cancer?","Question",{"text":63,"@type":64},"HDACs catalyze deacetylation of lysine residues on histones, altering DNA–histone interactions and thereby modulating binding of transcription factors and gene transcription.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What anticancer effects do HDAC inhibitors have?",{"text":68,"@type":64},"HDAC inhibitors prevent histone deacetylation, loosening nucleosome structure and enhancing gene transcription, and they exert anti-tumor actions such as inducing cell-cycle arrest and apoptosis.",{"name":70,"@type":61,"acceptedAnswer":71},"How do HDAC inhibitors relate to the tumor immune microenvironment?",{"text":72,"@type":64},"The inhibitors are described as enhancing tumor immunogenicity, which can support cancer immunotherapy and contribute to slowing tumor progression through microenvironment-mediated mechanisms.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370231,1790746453,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Zhang et al. European Journal  \nEuropean Journal of Medical Research (2025) 30:69  \n[https://doi.org/10.1186/s40001-025-02326-8](https://doi.org/10.1186/s40001-025-02326-8 of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-025-02326-8 of Medical Research)  \n REVIEW Open Access  \nTargeted intervention of tumor  \nmicroenvironment with HDAC inhibitors  \nand their combination therapy strategies  \nWanli Zhang1, Luqi Ge1, Yiwen Zhang2,3,4, Zhentao Zhang1, Wen Zhang1, Feifeng Song2,3*, Ping Huang2,3,4* and Tong Xu2,3*  \nAbstract  \nHistone deacetylation represents a significant epigenetic mechanism that involves the removal of acetyl groups from histones, subsequently influencing gene transcription. Overexpression of histone deacetylases (HDACs) is prevalent across various cancer types, positioning HDAC inhibitors as broadly applicable therapeutic agents. These inhibitors are known to enhance tumor immune antigenicity, potentially slowing tumor progression. Furthermore, the tumor microenvironment, which is intricately linked to cancer development, acts as a mediator in the proliferation of numerous cancers and presents a viable target for oncological therapies. This paper primarily explores how HDAC inhibitors can regulate cancer progression via the tumor microenvironment and suppress tumor growth through multiple pathways, in addition to examining the synergistic effects of combined drug therapies involving HDAC inhibitors. Keywords Histone deacetylase, Histone deacetylase inhibitors, Tumor, Tumor microenvironment  \nIntroduction  \nHistone modification is a pivotal epigenetic mechanism implicated in the development and progression of cancer [1]. HDAC and HAT interconversion is shown in Fig. 1A. Acetylation, a key histone modification, is crucial in maintaining physiological equilibrium within the  \n*Correspondence:  \nFeifeng Song [songfeifeng@hmc.edu.cn](songfeifeng@hmc.edu.cn)[ ](songfeifeng@hmc.edu.cn)Ping Huang [huangping@hmc.edu.cn](huangping@hmc.edu.cn)[ ](huangping@hmc.edu.cn)Tong Xu [21619007@zju.edu.cn](21619007@zju.edu.cn)  \n1 Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China  \n2 Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital(Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China  \n3 Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou 310014, China  \n4 Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, China  \nbody. Histone deacetylases, a group of proteases, catalyze the deacetylation of lysine residues, which are pivotal in chromosomal structural adjustments and gene expression regulation. The process of histone deacetylation impacts the interaction of DNA with histone octamers, consequently influencing the specific binding of various transcription factors and co-transcription factors to DNA binding sites, thereby modulating gene transcription. HDAC enzymes are ubiquitously present across organisms. In humans, 18 histone deacetylases have been identified and categorized into four major families according to the homology of transcriptional control factor sequences in yeast as class I, class II, class IV, and class III [2]. Notably, class I, II, and IV enzymes are Zn2 +-dependent proteins, while class III relies on NAD + as a cofactor. Figure 1B illustrates the classification of HDACs. HDACs play critical roles in various biological processes, such as transcriptional regulation through histone acetylation status, post-translational modification of proteins, and cellular proliferation and  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the sourc","cbCaioQoB7UL9IYy","https://ap.wps.com/l/cbCaioQoB7UL9IYy","pdf",1533261,12,"English","# Abstract\n# Introduction\n## HDACs as epigenetic regulators in cancer\n## HDAC inhibitor mechanisms and anticancer effects","[{\"question\":\"How do HDACs influence gene transcription in cancer?\",\"answer\":\"HDACs catalyze deacetylation of lysine residues on histones, altering DNA–histone interactions and thereby modulating binding of transcription factors and gene transcription.\"},{\"question\":\"What anticancer effects do HDAC inhibitors have?\",\"answer\":\"HDAC inhibitors prevent histone deacetylation, loosening nucleosome structure and enhancing gene transcription, and they exert anti-tumor actions such as inducing cell-cycle arrest and apoptosis.\"},{\"question\":\"How do HDAC inhibitors relate to the tumor immune microenvironment?\",\"answer\":\"The inhibitors are described as enhancing tumor immunogenicity, which can support cancer immunotherapy and contribute to slowing tumor progression through microenvironment-mediated mechanisms.\"}]","Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies | PDF",1790187506,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9749a3e82c1bae967c4a9ad7d2662f2a.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/171efff0227bc2f93deca4239eec8e8a.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14ff32a615bf84f3ed68d09ba9910584.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c1305d705ec6262dce13f53e8969d01.webp",980,1301]